BAY-474
CAS: 1033767-86-0
Ref. 3D-IRB76786
| 5mg | A consultar | |
| 10mg | A consultar | |
| 25mg | A consultar | |
| 50mg | A consultar | |
| 100mg | A consultar |
Información del producto
BAY-474 is a combination of two active compounds, vegfr and mapk inhibitors. It has been shown to be effective for the treatment of bladder cancer in vitro and in vivo. BAY-474 is administered intraperitoneally for prophylaxis purposes. BAY-474 may also be used for the treatment of other types of cancers that have a high incidence of vascular endothelial growth factor (VEGF) expression, such as nasal cancer. The drug is solvated with an organic solvent, which may help to stabilize the drug's activity and improve its pharmacokinetics.
Propiedades químicas
Consulta técnica sobre: 3D-IRB76786 BAY-474
Si desea solicitar un presupuesto o realizar un pedido, por favor añada los productos deseados a su carrito y solicite un presupuesto o pedido desde el carrito. Es más rápido, más barato, y podrá beneficiarse de los descuentos y las ventajas disponibles.
